The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia

Clinical Endocrinology

Volumn 60, Issue 4, 2004, Pages 457-460

  Teale, J D ^a   Wark, G ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; C PEPTIDE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOSE; INSULIN; PREDNISOLONE; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURGERY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FIBROMA; HUMAN; HYPOGLYCEMIA; LOW DRUG DOSE; LUNG CARCINOMA; MALE; PANCREAS TUMOR; PLEURA CANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA; RETROPERITONEAL CANCER; SOFT TISSUE SARCOMA; SPINDLE CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; C-PEPTIDE; FEMALE; GLUCOCORTICOIDS; HUMAN GROWTH HORMONE; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; NEOPLASMS; PREDNISOLONE; PROTEIN PRECURSORS;

EID: 1842784912     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.01989.x     Document Type: Article

References (11)

1. Baxter, R.C. & Daughaday, W.H. (1991) Impaired formation of the ternary insulin-like growth factor-binding complex in patients with hypoglycemia due to non-islet cell tumors. Journal of Clinical Endocrinology and Metabolism, 73, 696-702.
2. Baxter, R.C., Holman, S.R., Courbold, A., Stranks, S., Ho, P.J. & Braund, W. (1995) Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in non-islet cell tumor hypoglycemia. Journal of Clinical Endocrinology and Metabolism, 80, 2700-2708.
3. Daughaday, W.H., Trivedi, B. & Kapadia, M. (1981) Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor associated hypoglycemia. Journal of Clinical Endocrinology and Metabolism, 53, 289-294.
4. Daughaday, W.H., Trivedi, B. & Baxter, R. (1993) Serum big insulin-like growth factor-II from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proceedings of the National Academy of Sciences of USA, 90, 5823-5827.
5. Hoff, A.O. & Vassilopoulou-Sellin, R. (1998) The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer, 82, 1585-1592.
6. Holt, R.I.G., Teale, J.D., Jones, J.S., Quin, J.D., McGregor, A.M. & Miell, J.P. (1998) Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet tumour hypoglycaemia. Growth Hormone and IGF Research, 8, 447-454.
7. Holt, R.I.G., Simpson, H.L. & Sonksen, P.H. (2003) The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabetic Medicine, 20, 3-15.
8. Horber, F.F., Marsch, H.M. & Haymond, M.W. (1991) Differential effects of prednisolone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes, 40, 141-149.
9. Koch, C.A., Rother, K.I. & Roth, J. (1999) Tumor hypoglycemia linked to IGF-II. In: The IGF System: Molecular Biology, Physiology and Clinical Applications (eds R. G. Rosenfeld and C. R. Jr Roberts), pp. 675-698. Humana Press, Totowa, NJ.
10. Teale, J.D. & Marks, V. (1998) Glucocorticosteroid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia. Clinical Endocrinology, 49, 491-498.
11. Zapf, J., Walter, H. & Froesch, E.R. (1981) Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. Journal of Clinical Investigation, 68, 1321-1330.